News & Opinion
Top 10 Innovations
Cell & Molecular Biology
Disease & Medicine
Ecology & Environment
Genetics & Genomics
Pharma & Biotech
Image of the Day
Opinion: Balancing Risks and Rewards of CAR T-Cell Therapy
David Harris | Dec 15, 2016
New approaches to treating cancer have shown great promise, but they also come with serious risks that give us cause for concern.
FDA Approves Clinical Trials to Test Cuban Cancer Vaccine
Bob Grant | Oct 31, 2016
An early-stage study of the effectiveness of a lung-cancer vaccine developed by scientists in Cuba could start as early as next month.
Cuban-U.S. Research Collaborations Easier Now
Kerry Grens | Oct 18, 2016
President Obama’s executive actions remove some of the red tape for American and Cuban scientists to work together.
Alzheimer’s Immunotherapy Pioneer Dies
Ben Andrew Henry | Oct 11, 2016
Dale Schenk, who worked to develop a vaccine for Alzheimer’s disease, has passed away at age 59.
Immunotherapy for Alzheimer’s Disease Shows Promise
Alison F. Takemura | Aug 31, 2016
Biogen’s aducanumab reduces amyloid-β plaques in a dose-dependent manner, according to interim results of a Phase 1b clinical trial.
Toward an Immunotherapy for Alzheimer’s Disease
Tanya Lewis | Jul 28, 2016
Targeting tau antibodies does not require effector function, researchers report.
CRISPR Therapy to Enter Trials
Jef Akst | Jul 25, 2016
Researchers in China will use the CRISPR-Cas9 system to edit T cells extracted from patients with cancer before those cells are returned to the body to target malignant ones.
Cancer Immunotherapy Trial Suspended After Deaths
Kerry Grens | Jul 8, 2016
Juno Therapeutics asks the US Food and Drug Administration for permission to restart the CAR-T experiments without chemotherapy.
Sex Differences in Immune Response
Tanya Lewis | Jun 21, 2016
Female mice lacking an immune receptor are better than males at fighting certain viral infections.
TS Picks: June 6, 2016
Jef Akst | Jun 6, 2016
American Society of Clinical Oncology meeting edition